Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
70,610 ILa | -0.01% | -2.22% | -2.61% |
Sales 2024 * | 2.72B 1,010B | Sales 2025 * | 3.04B 1,128B | Capitalization | 12.09B 4,483B |
---|---|---|---|---|---|
Net income 2024 * | 449M 166B | Net income 2025 * | 549M 204B | EV / Sales 2024 * | 3.9 x |
Net cash position 2024 * | 1.46B 540B | Net cash position 2025 * | 2.25B 835B | EV / Sales 2025 * | 3.23 x |
P/E ratio 2024 * |
27.4
x | P/E ratio 2025 * |
21.3
x | Employees | 8,384 |
Yield 2024 * |
0.02% | Yield 2025 * |
-
| Free-Float | 84.08% |
Latest transcript on NICE Ltd.
1 day | -0.01% | ||
1 week | -2.22% | ||
1 month | -15.32% | ||
3 months | -19.46% | ||
6 months | -1.47% | ||
Current year | -2.61% |
Managers | Title | Age | Since |
---|---|---|---|
Barak Eilam
CEO | Chief Executive Officer | 49 | 14-04-29 |
Darren Rushworth
PSD | President | 56 | 16-12-31 |
Mary Gaspich
DFI | Director of Finance/CFO | 59 | 16-09-30 |
Members of the board | Title | Age | Since |
---|---|---|---|
Léo Apotheker
BRD | Director/Board Member | 69 | 13-07-31 |
David Kostman
CHM | Chairman | 59 | 00-12-31 |
Dan Falk
BRD | Director/Board Member | 79 | 00-12-31 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.58% | 17 M€ | +6.09% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-30 | 70,610 | -0.01% | 204,965 |
24-05-29 | 70,620 | -0.44% | 84,350 |
24-05-28 | 70,930 | +1.14% | 69,375 |
24-05-27 | 70,130 | +0.47% | 51,252 |
24-05-26 | 69,800 | -3.34% | 52,940 |
Delayed Quote TEL AVIV STOCK EXCHANGE, May 30, 2024 at 10:24 am EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-2.61% | 12.07B | |
+8.91% | 85.92B | |
+5.14% | 77.91B | |
-16.20% | 52.89B | |
+26.18% | 48.28B | |
+28.93% | 45.38B | |
-34.05% | 40.83B | |
+66.72% | 38.78B | |
-0.36% | 27.48B | |
-26.47% | 21.52B |
- Stock Market
- Equities
- NICE Stock